Genetic Dilemmas: Reproductive Technology, Parental Choices, and Children's Futures, by Dena Davis. London: Routledge, 2000. 224 pp. $22.95.

2002 ◽  
Vol 11 (1) ◽  
pp. 102-105
Author(s):  
Jeffrey R. Botkin

Imagine a genetic counselor working with a young couple pregnant with their first child. The explosion of genetic knowledge and technology in recent years is complicating this professional relationship as a host of new choices brings a few clients with atypical needs. This couple is deaf. They seek not to avoid a child with their disability but rather to assure that the child too will be deaf—a child to share their culture and perspectives on the world. If prenatal diagnosis indicates that the prospective child would be hearing, they intend to terminate the pregnancy and try again. So, how should the counselor respond to this request for services? Does a traditional deference to parental autonomy in reproductive matters require that we respect such decisions by informed couples? More broadly, what are the concepts by which society will guide policy in this new and sensitive domain?

Blood ◽  
1986 ◽  
Vol 68 (4) ◽  
pp. 964-966
Author(s):  
HH Jr Kazazian ◽  
CE Dowling ◽  
PG Waber ◽  
S Huang ◽  
WH Lo

To make possible prenatal diagnosis of beta-thalassemia in China and Southeast Asia by direct detection of mutant beta-globin genes, we have determined the spectrum of mutations producing the disorder in this region of the world. Seventy-eight beta-thalassemia genes from Chinese and Southeast Asians were randomly obtained, and the relevant mutation was characterized in 76 (98%) of them. Seven different point mutations were found among the 78 genes studied. Of these seven beta-thalassemia alleles, two constitute 62%, and two others account for 29% of the total. Since only four alleles make up 91% of the mutant genes, prenatal diagnosis of beta-thalassemia in China and Southeast Asia should be feasible by simplified techniques for direct detection of point mutations.


2009 ◽  
Vol 18 (3) ◽  
pp. 228-235 ◽  
Author(s):  
INMACULADA DE MELO-MARTÍN

It might come as a surprise to many that Spain, a country with a strong Catholic tradition that officially banned contraceptive technologies until 1978, has some of the most liberal regulations in assisted reproduction in the world. Law No. 35/1988 was one of the first and most detailed acts of legislation undertaken on the subject of assisted-conception procedures. Indeed, not only did the law permit research on nonviable embryos, it made assisted reproductive technologies available to any woman, whether married or not, through the national healthcare system.


2020 ◽  
Vol 2 (1) ◽  
pp. 86-111
Author(s):  
Thomas McGee

This article responds to the literature gap within both discourses on ‘sexual citizenship’ and statelessness studies on the nexus between statelessness and sexual orientation, gender identity and expression, and sex characteristics (‘SOGIESC’). It explores the intersectional experiences of stateless lesbian, gay, bisexual, transgender, intersex and queer plus (‘LGBTIQ+’) individuals as well as circumstances in which discrimination on SOGIESC grounds can cause statelessness for LGBTIQ+ persons or their children. In addition to rare reports of arbitrary deprivation of citizenship from LGBTIQ+ persons, the non-recognition of post-transition statuses and intersex realities may lead to situations of statelessness. Finally, complex legislation and administrative practices around assisted reproductive technology — and especially international commercial surrogacy — can leave children born within ‘rainbow families’ at particular risk of statelessness. In arguing that a global nexus does indeed exist between SOGIESC and statelessness, this article calls for further empirical research in order to provide greater nuance and context-specific understandings of the intersectional experiences and causes of statelessness for LGBTIQ+ individuals around the world.


2020 ◽  
Vol 8 (8) ◽  
pp. 4138-4143
Author(s):  
Kori V. K. ◽  
Renu Rani

As a tourist destination, India gets a highest place in the world. Foreigners arrive to India not only to sight seen or pilgrims, but also for education, medical treatment, and employment. According to the FTA data Indian tourism is being increased annually. Medical tourism is also one of them and India is the 2nd most popular country in this. Especially Man, Materials and Money are the important factors there. India is rich in skilled human resources like medical specialists, paramedical and supportive staffs and laborers. Materi-als also can be found easily due to developed industries and lots of natural resources. High availability of all these factors lessens the cost. As far as medical tourism is concerned, most sub fertile European couples come to India for the help of Assisted Reproductive Technology, where Indian women are used for surrogacy. They select the Indian women for this purpose due the loose-fitting of rules and regulations in India. But after implantation, those mothers are brought to countries like Dubai as anti-natal sex detection is prohibited in India. So, the process becomes reversed. Ayurveda can help to prevent those incidents be-cause Ayurveda has an excellent methodology to make a better progeny with Rasayana, Vaajeekarana and especially in the field of Kaumarbhritya. Ayurveda Acharyas have mentioned the infertility management, Garbhadhana Samaskara, Garbhini Paricharya, Punsawana Karma etc. to have a healthy child with a desired. Hence necessary steps can be taken by the relevant authorities like AYUSH in order to change the Assisted Reproductive Technology in to Ayurvedic Reproductive Technology.


2019 ◽  
Vol 01 (04) ◽  
pp. 187-192
Author(s):  
Sujoy Dasgupta

Background: In 2010, The World Health Organization (WHO) suggested the standards of reporting of semen analysis and the reference values. We tried to determine the adherence to the WHO 2010 standard regarding semen analysis among the laboratories of West Bengal. Methods: An observational study was carried out by collecting the semen analysis reports from different laboratories. Compliance with the WHO 2010 recommendations regarding the reporting of semen analysis and references mentioned was subsequently analyzed. Results: A total of 211 laboratory reports were collected; of which 15 were ART (Assisted Reproductive Technology)-laboratories (7%) and 196 were non-ART-laboratories (93%). More than half of the laboratories did not mention any reference values. Only 7.5% used the phrase “WHO 2010” as the reference. Only 3% of the laboratories reported all the six “important” parameters (volume, pH, sperm concentration, motility, morphology and vitality) and used the WHO 2010 references for all of them. The ART laboratories performed significantly better than their non-ART counterparts in reporting and quoting the WHO 2010 reference values. Conclusion: Even nine years after its introduction, the compliance with the WHO 2010 recommendations on semen analysis was still low among our laboratories. There is need for increased awareness for the laboratory persons in this regard.


Author(s):  
Bamgboye M Afolabi ◽  
Abayomi B Ajayi ◽  
Tola Ajayi ◽  
Victor D Ajayi ◽  
Ifeoluwa Oyetunji ◽  
...  

Introduction: COVID-19 pandemic has taken the world by storm and consequently, various reproductive medicine societies had since issued guidelines based on best judgement for the safety of IVF patients and attending health staffs Objective: The objective of this study was to assess the opinions of IVF staff in sub-Sahara Africa on the awareness of COVID-19 on Assisted Reproductive Technology. The study also evaluated some of the measures that can mitigate the effects of the virus in IVF clinics. Methodology: Different cadres of staff at Nordica Fertility Center (NFC) in Lagos, Nigeria were interviewed. Those interviewed included the Medical Director, Clinicians/Gynecologists, Clinic Manager, Nurses, Embryologists, Counsellor, Business Developing Unit, Client Liaison Officers and Accounts Officer. Their responses were collated, and the key points were documented. Each staff in face mask was visited by one interviewer who observed all government-recommended sanitary precautions including wearing a facemask and maintaining social distance between her and the interviewee. Result: The response of the MD on the fate of IVF clinic in Africa within the next 6 months to 1 year of the Covid-19 pandemic was that the overall economy is a major determinant of the ability of clients to pay for IVF services. Infertile women would still want to have children but “how would they pay for the services?” since ART is not subsidized by the government but mostly paid as out-of-pocket expense in this part of the world. The main points were that IVF clinics are not immune to the economy and vaccine may or may not favor IVF, reasons being; The virus is about 5 months old hence still much to be discovered There is no solid evidence that the virus affects reproduction No evidence of mother-to-child transmission and The virus can survive in cold environment therefore, it could survive cryopreservation. The embryologist was of the opinion that IVF clinics in Africa need to understand the virus more to decide whether: Attend to COVID-19 patients or not and if so, how best to care for them Better prepare modalities of cryopreservation such as Appropriate equipment Batching gametes together with HIV or Hepatitis patients In same or separate equipment and Getting special cryo-tanks for Covid-19 patients. Embryologist agreed that clinics will be able to perform other adjunct fertility treatment such as Pre-implantation Genetic Diagnosis (PGD), dependent on clinics’ ability to have separate equipment for Covid19-positive and negative patients. Conclusion: Africa is not left behind in experiencing the effects of COVID-19 and ART, for which concerns for the survival of privately owned clinics to ensure and safeguard the health and safety of patients, staff and the unborn babies are expressed. As of now, no-one is sure of patients that are symptomatic and those not symptomatic, as testing in the country, just like in most parts of the world, are still inadequate. When a vaccine is available, it may be mandatory for every IVF patient to get a shot. The main points of other cadres of staff are discussed.


Sign in / Sign up

Export Citation Format

Share Document